D Cattaneo
Overview
Explore the profile of D Cattaneo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
496
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Palandri F, Auteri G, Abruzzese E, Caocci G, Bonifacio M, Mendicino F, et al.
Ann Hematol
. 2024 Mar;
103(6):1931-1940.
PMID: 38478023
Ruxolitinib is beneficial in patients with myelofibrosis (MF) and polycythemia vera (PV). Information on ruxolitinib adherence is scant. The Ruxolitinib Adherence in Myelofibrosis and Polycythemia Vera (RAMP) prospective multicenter study...
2.
Cereda G, Lazzaretti M, Colli C, Fontana E, Enrico P, Pigoni A, et al.
Schizophr Res
. 2023 Sep;
261:15-17.
PMID: 37683423
No abstract available.
3.
Iurlo A, Cattaneo D, Consonni D, Castagnetti F, Miggiano M, Binotto G, et al.
Front Pharmacol
. 2023 Apr;
14:1154377.
PMID: 37033642
TKIs long-term treatment in CML may lead to persistent adverse events (AEs) that can promote relevant morbidity and mortality. Consequently, TKIs dose reduction is often used to prevent AEs. However,...
4.
Cattaneo D, Pasina L, Conti F, Giacomelli A, Oreni L, Pezzati L, et al.
J Endocrinol Invest
. 2021 May;
44(12):2849-2851.
PMID: 34053008
No abstract available.
5.
Gamberini G, Masuccio F, Ferriero G, Cattaneo D, Solaro C
J Affect Disord
. 2021 Mar;
286:108-109.
PMID: 33714170
No abstract available.
6.
Angelini L, Carpinella I, Cattaneo D, Ferrarin M, Gervasoni E, Sharrack B, et al.
Gait Posture
. 2021 Feb;
PMID: 33518426
This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can...
7.
Germanotta M, Cruciani A, Galli C, Cattaneo D, Spedicato A, Aprile I
J Biol Regul Homeost Agents
. 2021 Jan;
34(5 Suppl. 3).
PMID: 33386050
Upper limb recovery is a complex process and a strong challenge in the rehabilitation of patients after stroke. Several studies have been conducted to compare the efficacy of conventional and...
8.
Solaro C, Grange E, Di Giovanni R, Cattaneo D, Bertoni R, Prosperini L, et al.
Mult Scler Relat Disord
. 2020 Jul;
45:102422.
PMID: 32731199
Background: The Expanded Disability Status Scale (EDSS) is the most frequently used scale to measure neurologic impairment and quantify the level of disability in Multiple Sclerosis (MS) even though the...
9.
Solaro C, Di Giovanni R, Grange E, Mueller M, Messmer Uccelli M, Bertoni R, et al.
Eur J Neurol
. 2020 Jul;
27(12):2523-2530.
PMID: 32619066
Background And Purpose: Limited data are available in the literature for upper limb impairment in multiple sclerosis (MS). This study aimed to report the distribution of values of hand grip...
10.
Martson A, Sturkenboom M, Stojanova J, Cattaneo D, Hope W, Marriott D, et al.
Clin Microbiol Infect
. 2020 Mar;
26(8):1008-1016.
PMID: 32205294
Background: Therapeutic drug monitoring (TDM) is a tool to personalize and optimize dosing by measuring the drug concentration and subsequently adjusting the dose to reach a target concentration or exposure....